Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
Key Points Melbourne, Australia, July 6, 2026: Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to announce that it has engaged Pullan Consulting to provide business development services to assist…